8-K - Dyne Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Financial Results

Disclosure

Mandatory

Variant

8-K

Items Reported

2.02

Results of Operations and Financial Condition. On March 2, 2026, Dyne Therapeutics, Inc. (the “Company”) issued a press release announcing the Company’s financi

Financial Results

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 104 Press Release issued by Dyne Therapeutics, Inc. on March 2, 2026 Cover Page Int

Exhibits Only

Exhibits (2)

8-K

99.1

EX-99.1